Combined negative pressure wound therapy with irrigation and dwell time and artificial dermis prevents infection and promotes granulation formation in a ruptured giant omphalocele: a case report.
Negative pressure wound therapy
Negative pressure wound therapy with irrigation and dwell time
Omphalocele
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
26 11 2022
26 11 2022
Historique:
received:
16
06
2022
accepted:
15
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
30
11
2022
Statut:
epublish
Résumé
Omphalocele is a congenital abdominal wall defect of the umbilical cord insertion site. A giant omphalocele, with a fascial defect > 5 cm in diameter and/or containing > 50% of the liver within the hernia sac, can be challenging for pediatric surgeons. Recently, negative pressure wound therapy has been reported as an effective management for giant omphaloceles; however, it is not recommended for an infected wound with necrotic tissue as it may exacerbate infection. We adopted negative pressure wound therapy with irrigation and dwell time (NPWTi-d) for a case of a ruptured giant omphalocele. Artificial membranes, followed by artificial dermis, were used to promote fibrous capsule formation, and then NPWTi-d was used to promote granulation while controlling infection. However, studies have not been conducted regarding NPWTi-d for ruptured giant omphaloceles; hence, we present our treatment experience with NPWTi-d for a giant omphalocele. The patient was a boy born at 38 weeks and 3 days of gestation, weighing 1896 g. He was diagnosed with a ruptured giant omphalocele with a total liver and intestine defect hole of 10 cm × 10 cm. The patient underwent silo placement using an artificial mesh, followed by plicating the artificial mesh at 4 days of age. The herniated viscera were gradually reduced into the abdominal cavity; however, the defect size was still large. Hence, a collagen-based artificial dermis was patched on the defect hole. After creating a fresh and smooth granulated tissue, NPWTi-d was applied at 33 days of age to promote granulation and control infection. We used the 3 M™ V.A.C.® Ulta Therapy Unit with 3 M™ VeraFlo™ therapy. NPWTi-d was stopped at 60 days of age when the granulation tissue was well formed including at the artificial dermis site. The wound was managed with prostandin ointment and appropriate debridement, resulting in complete epithelialization at 5 months of age. Artificial membranes followed by artificial dermis were used to promote a fibrous capsule and artificial dermis granulation, which protects against organ damage. NPWTi-d achieved better control of infection and promoted wound healing. NPWTi-d combined with artificial dermis can effectively treat ruptured giant omphaloceles.
Sections du résumé
BACKGROUND
Omphalocele is a congenital abdominal wall defect of the umbilical cord insertion site. A giant omphalocele, with a fascial defect > 5 cm in diameter and/or containing > 50% of the liver within the hernia sac, can be challenging for pediatric surgeons. Recently, negative pressure wound therapy has been reported as an effective management for giant omphaloceles; however, it is not recommended for an infected wound with necrotic tissue as it may exacerbate infection. We adopted negative pressure wound therapy with irrigation and dwell time (NPWTi-d) for a case of a ruptured giant omphalocele. Artificial membranes, followed by artificial dermis, were used to promote fibrous capsule formation, and then NPWTi-d was used to promote granulation while controlling infection. However, studies have not been conducted regarding NPWTi-d for ruptured giant omphaloceles; hence, we present our treatment experience with NPWTi-d for a giant omphalocele.
CASE PRESENTATION
The patient was a boy born at 38 weeks and 3 days of gestation, weighing 1896 g. He was diagnosed with a ruptured giant omphalocele with a total liver and intestine defect hole of 10 cm × 10 cm. The patient underwent silo placement using an artificial mesh, followed by plicating the artificial mesh at 4 days of age. The herniated viscera were gradually reduced into the abdominal cavity; however, the defect size was still large. Hence, a collagen-based artificial dermis was patched on the defect hole. After creating a fresh and smooth granulated tissue, NPWTi-d was applied at 33 days of age to promote granulation and control infection. We used the 3 M™ V.A.C.® Ulta Therapy Unit with 3 M™ VeraFlo™ therapy. NPWTi-d was stopped at 60 days of age when the granulation tissue was well formed including at the artificial dermis site. The wound was managed with prostandin ointment and appropriate debridement, resulting in complete epithelialization at 5 months of age.
CONCLUSIONS
Artificial membranes followed by artificial dermis were used to promote a fibrous capsule and artificial dermis granulation, which protects against organ damage. NPWTi-d achieved better control of infection and promoted wound healing. NPWTi-d combined with artificial dermis can effectively treat ruptured giant omphaloceles.
Identifiants
pubmed: 36435753
doi: 10.1186/s12887-022-03755-8
pii: 10.1186/s12887-022-03755-8
pmc: PMC9701383
doi:
Substances chimiques
Membranes, Artificial
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
680Informations de copyright
© 2022. The Author(s).
Références
J Surg Res. 2013 Sep;184(1):658-64
pubmed: 23768766
Int Wound J. 2013 Dec;10 Suppl 1:56-60
pubmed: 24251845
Ann Plast Surg. 2007 May;58(5):536-40
pubmed: 17452839
J Cardiothorac Surg. 2011 Feb 09;6:16
pubmed: 21306630
Int Wound J. 2008 Jun;5(3):399-413
pubmed: 18593390
Plast Reconstr Surg. 2004 Apr 15;113(5):1339-46
pubmed: 15060345
Wounds. 2011 Oct;23(10):309-19
pubmed: 25881108
Semin Pediatr Surg. 2019 Apr;28(2):101-105
pubmed: 31072456
Semin Pediatr Surg. 2019 Apr;28(2):80-83
pubmed: 31072462
Curr Probl Surg. 1982 Apr;19(4):157-213
pubmed: 6211335
J Am Coll Clin Wound Spec. 2014 Feb 20;4(4):74-80
pubmed: 26199877
Cells Tissues Organs. 2000;167(2-3):88-94
pubmed: 10971033
Chirurgia (Bucur). 2014 Jul-Aug;109(4):507-13
pubmed: 25149614
Ann Plast Surg. 2012 Jul;69(1):104-8
pubmed: 21659845
BMJ. 2009 Jun 24;338:b2269
pubmed: 19553260
Am J Surg. 2008 Jul;196(1):1-2
pubmed: 18355795
J Pediatr Surg. 2006 Jan;41(1):212-5
pubmed: 16410135
J Plast Reconstr Aesthet Surg. 2013 Dec;66(12):e373-5
pubmed: 23721627
J Wound Care. 2009 Jan;18(1):24-5
pubmed: 19131914
J Burn Care Rehabil. 2003 Jan-Feb;24(1):42-8
pubmed: 12543990
J Thorac Cardiovasc Surg. 2010 Nov;140(5):1133-6
pubmed: 20832086
Colorectal Dis. 2007 Mar;9(3):266-8
pubmed: 17298627
Am J Surg. 2016 Mar;211(3):605-9
pubmed: 26778271
Pediatr Surg Int. 2014 Apr;30(4):407-11
pubmed: 24509569
Minerva Pediatr. 2018 Jun;70(3):289-295
pubmed: 29160639
J Pediatr Surg. 2013 Dec;48(12):2525-9
pubmed: 24314197
Int J Low Extrem Wounds. 2008 Mar;7(1):51
pubmed: 18372273
Ther Clin Risk Manag. 2021 Apr 22;17:357-364
pubmed: 33911871
Plast Reconstr Surg. 2013 Dec;132(6):1569-1579
pubmed: 24005370
Int Wound J. 2011 Jun;8(3):261-7
pubmed: 21561535